Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
12.45
-2.05 (-14.14%)
At close: Nov 20, 2024, 4:00 PM
13.07
+0.62 (4.98%)
After-hours: Nov 20, 2024, 4:08 PM EST
Zenas BioPharma Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Zenas BioPharma stock have an average target of 36.75, with a low estimate of 27 and a high estimate of 45. The average target predicts an increase of 195.18% from the current stock price of 12.45.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 8, 2024.
Analyst Ratings
The average analyst rating for ZBIO stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 |
---|---|---|
Strong Buy | 3 | 3 |
Buy | 1 | 1 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +116.87% | Oct 8, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +181.12% | Oct 8, 2024 |
Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +221.29% | Oct 8, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +261.45% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
n/a
from 50.00M
Revenue Next Year
n/a
EPS This Year
-7.71
from -24.25
EPS Next Year
-4.13
from -7.71
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | 89.3M |
Avg | n/a | n/a | 43.4M |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -4.87 | -3.92 | -1.59 |
Avg | -7.71 | -4.13 | -3.15 |
Low | -13.07 | -4.29 | -3.91 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.